Does Astria Therapeutics (ATXS) Have the Potential to Rally 333.88% as Wall Street Analysts Expect?

Shares of Astria Therapeutics, Inc. (ATXS) have gained 8.3% over the past four weeks to close the last trading session at $6.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29.33 indicates a potential upside of 333.9%.The average comprises nine short-term price targets ranging from a low of $16.00 to a high of $49.00, with a standard deviation of $9.19. While the lowest est ...